Compare Medtronic PLC (MDT) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs PayPal Holdings, Inc. — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while PayPal Holdings, Inc. trades at $55.53 (market cap $47.07B). The key difference: Medtronic PLC is far larger — about 2.4× PayPal Holdings, Inc.'s market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and PayPal Holdings, Inc. for 106 Days on average.
| MDT | PYPL | |
|---|---|---|
Market Cap | $112.24B | $47.07B |
Volume | 105,663,236 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $105.35 | $75.75 |
52-Week Low | $73.75 | $39.08 |
Typical Hold Time | 63 Days | 106 Days |
Enterprise Value | $131.58B | $49.21B |
Dividend Yield | 3.28% | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
PayPal (PYPL) trades at $55.02, up 0.13% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a P/E of 10.4, net income margin of 14.36%, and recent earnings beats. Recent news highlights a Meta partnership for AI-powered checkout, potentially driving growth. Cash flow remains healthy with $1.53B net cash flow in 2025.
PYPL presents a value opportunity with attractive valuation multiples and solid profitability, though competition in digital payments and slowing branded checkout growth pose risks. Analyst consensus is mixed with a $56.41 price target, suggesting modest upside from current levels. The Meta partnership and cost-cutting initiatives under new CEO Enrique Lores provide catalysts for potential re-rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
